Health News Releases

February 02, 2017 10:30

Takeda Reports Q3 FY2016 Results and Improves Year-End Outlook

Takeda Pharmaceutical Company Limited (TOKYO: 4502): Strong Q3 year-to-date (YTD) results propelled by Growth Drivers · Underlying Revenue grew +7.4%, with Takeda's Growth Drivers (GI, Oncology,

February 01, 2017 16:08

Daemyung Optical to exhibit at global optic fair in SIOF and MIDO 2017

Daemyung Optical Co., Ltd. announced that it will be exhibiting at the International Eyewear Show MIDO 2017, which will be held in Fieramilano Rho-Pero Pavilions, Milan, Italy, from Feb. 25th to 27th,

February 01, 2017 13:30

Chiltern Expands Footprint in Bangalore, India, to Meet Global Data Demand

Chiltern, a leading global contract research organization, has announced the opening of its new process and technology center in Bangalore, India. The new office is a direct result of the company’s co

February 01, 2017 10:55

Exelixis and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan

Exelixis, Inc. (NASDAQ:EXEL) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced an exclusive licensing agreement for the commercialization and further clinical development in Japan o

January 31, 2017 14:00

Vice President Joe Biden to Deliver Keynote Remarks at 5th Annual World Patient Safety, Science & Technology Summit

The Patient Safety Movement Foundation (PSMF) announced today that former Vice President Joe Biden will deliver the keynote address on the first day of the 5th Annual World Patient Safety, Science & T

January 31, 2017 11:40

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

W. L. Gore & Associates (Gore) has announced that the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received U.S. Food & Drug Administration (FDA) approval for treatment o

January 31, 2017 09:15

Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced today that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris’ proprieta

January 30, 2017 09:55

Jardiance® (empagliflozin) becomes first type 2 diabetes medicine in the EU to include cardiovascular death reduction data in label

The European Commission has approved an update to the Jardiance® (empagliflozin) label to include a change to the indication statement. Jardiance® is now indicated for the treatment of adults with ins

January 23, 2017 10:40

Takeda Recognized as One of the Global 100 Most Sustainable Corporations for Second Consecutive Year

Takeda Pharmaceutical Company Limited [TOKYO:4502], (“Takeda”) is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index. Takeda achieved this d

January 20, 2017 15:55

Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced the commencement of the cash tender offer by its wholly-owned indirect subsidiary, Kiku Merger Co., Inc., for all outstand

January 20, 2017 15:25

For the 1st Time, the Annual World Patient Safety, Science & Technology Summit Will Be Streamed Live in HD Outside of the United States

The Patient Safety Movement Foundation (PSMF) announced today that it will offer livestreaming of the sold-out 5th annual World Patient Safety, Science & Technology Summit to viewers outside of the Un

January 20, 2017 15:00

InFo 124M - Swiss Made EDOF IOL for Cataract Surgery

The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com) continues to expand its portfolio of intraocular lenses (IOLs) announcing the launch of a new product range based on the first InFo ser

January 19, 2017 11:40

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Boehringer Ingelheim announced today that BI 695501, its adalimumab biosimilar candidate to Humira®*, has been accepted for regulatory review by the European Medicines Agency (EMA) and the U.S Food an

January 18, 2017 11:25

Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia

Bioventus, a leader in orthobiologic solutions, announced it has selected MEDSERVICE to distribute DUROLANE® in Russia. DUROLANE is a single-injection joint-fluid based on a natural, safe and proven t

January 16, 2017 13:25

Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to South Korea

Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced its randomized, controlled Phase 2/3 clinical trial, called Toca 5, is now enrolling patients in South Korea. The

January 12, 2017 17:33

HUREN awarded citation by Korean Optometric Association

Daemyung Optical’s brand ‘HUREN (www.huren.co.kr)', carrying out an aggressive marketing in the Optical lens sector, was awarded a citation by Daejeon Metropolitan City Eyeglass Society for the Korean

January 12, 2017 11:20

Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that they have entered a collaboration to develop Maverick’s T-cell e

January 10, 2017 16:50

Market Research Proves Success of Galderma’s Harmony Programme for Aesthetic Practice

Market research concludes that Galderma’s Harmony Programme for aesthetic Health Care Professionals (HCPs) significantly increases patient satisfaction. Using Harmony resulted in more returning patien

January 10, 2017 11:05

Ferring Partners with Intralytix to Develop Bacteriophage Treatments for Conditions Associated with the Microbiome and Drug-Resistant Bacteria

Ferring Pharmaceuticals is partnering with Intralytix, Inc to develop and commercialise bacteriophage-based treatments for conditions associated with the presence of pathogenic bacteria or dysbiosis o

January 10, 2017 10:50

Takeda to Acquire ARIAD Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) today announced that they have entered into a definitive agreement under which Taked

January 09, 2017 10:55

LFB S.A. Announced Today the Acceptance by U.S. Food and Drug Administration of the Filed Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of Coagulation Factor VIIa (Recombinant) as a treatment for congenital hemophilia A or B in adolescent an

January 09, 2017 08:35

Takeda and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) and PvP Biologics, Inc. (“PvP”) today announced a global agreement for the development of KumaMax, a novel enzyme designed to break down t

January 06, 2017 13:35

BridgeBio Pharma Launches with a Focus on Precision Medicines for Genetic Diseases

California-based BridgeBio Pharma has come out of stealth mode to reveal more detail about its novel approach to developing new therapies for genetic diseases. These diseases, often inherited and indi

January 04, 2017 13:35

Patient Safety Movement Announces the 3rd Fishing Trip with President Jimmy Carter & First Lady Rosalynn

The Patient Safety Movement Foundation (PSMF) announces its third annual contest to win a fishing trip with former President Jimmy Carter and First Lady Rosalynn Carter. The top two healthcare institu

January 04, 2017 12:00

Hong Kong Professor in Food & Nutritional Sciences Appointed to the Herbalife Nutrition Advisory Board

Herbalife, a global nutrition company, today announced that Dr. Zhen-Yu Chen, an expert in food and nutritional sciences has been appointed to its Nutrition Advisory Board (NAB). Dr. Chen has over

News by Region

News by Industry